Dr. Reddy’s Laboratories Ltd. is an integrated global pharmaceutical company with a commercial presence in more than 20 countries, and wholly-owned subsidiaries in US, UK, Russia, Germany and Brazil and joint ventures in China, South Africa and Australia. Dr. Reddy’s has over 20,000 employees working across the globe and a network of 25 manufacturing facilities and seven R&D centres, including Cambridge.
In our Cambridge laboratories, Dr Reddy’s develops and uses advanced chemistry skills, including world-leading bio- and chemocatalysis technology, to develop routes to APIs. Projects are performed for both internal customers and, via our Custom Pharma Services division, for external customers. Our main focus is developing technical solutions for the production of complex single enantiomer intermediates and APIs. Our technologies enable cleaner, quicker, and more efficient routes to these target molecules. The site was founded more than 25 years ago and has been part of Dr Reddy’s since 2008.